Est. 2001·3,000+ placements · six offices · four regions
Product Launchcurated sourcedetected 2026-07-31 · confidence 80%

Last updated

LexisNexis Risk Solutions: Product Launch

LexisNexis Risk Solutions released findings from its 2026 Global Cybercrime Report analyzing 116.1 billion transactions. Report highlights include 59% jump in automated bot attacks that now mimic human behavior, 89% YoY increase in login attack rates, and $442 billion in estimated global fraud losses (2025). Findings framed around fintech fraud prevention webinar in Asia.

Source: Fintechnews Singapore

The leadership read

The report's operational weight sits in what the transaction data reveals about where fraud controls are failing, not just that fraud is rising. Analysing 116.1 billion transactions, LexisNexis has documented a structural shift: the attack surface has migrated away from onboarding, where identity verification investment has been heaviest, toward authenticated sessions, with login attack rates nearly doubling year-on-year. Simultaneously, authorised push payment fraud has reached a scale where technical controls are largely irrelevant; the customer is authentic, the device is genuine, and the authorization is real. That combination commits any institution using this data to rebuilding fraud logic around behavioral signals and post-authentication monitoring rather than front-door identity checks alone. The related signals we have tracked over the last 90 days are thinly matched to this specific theme, the comparable set is dominated by unrelated product launches across defense, consumer goods, and quantum hardware. However, the fintech-adjacent signals, including BNY's expansion of institutional digital asset custody and N3XT's MCP-enabled B2B payments infrastructure, point to a consistent underlying dynamic: financial institutions are extending the transaction perimeter into new channels and protocols faster than risk architecture is following. That gap is precisely where the LexisNexis data is most alarming. Across fintechs and financial institutions operating in Asia's cross-border and embedded finance corridors, this pattern is concentrating demand for risk and product leadership with behavioral analytics depth, specifically operators who can design friction-calibrated trust layers that function across heterogeneous regulatory regimes. APAC's fragmented licensing environment makes this harder than equivalent work in Europe or North America. Commercial and product leadership at the seam between fraud operations and customer experience is where the functional pressure is sharpest.

Market context: Backdrop: a 100.3 (Neutral) Talent Market Index (down 1 on the month) with Asia activity steady (-1.3pts).

LexisNexis Risk Solutions: 3 signals in the last 90 days; 0.2% of MitchelLake's EMEA signal flow; 4 tracked across 77 days.

MitchelLake in this thematic

Also at LexisNexis Risk Solutions

More signals across Asia

Product Launch · Asia

Agoda

Agoda launched refreshed Agoda Partner Portal (upgraded from Yield Control System), a unified business management platform with AI-powered insights, dynamic pricing, and regional adaptations including KakaoTalk notifications

Product Launch · Asia

Larsen & Toubro

Indian engineering firm L&T announced deployment of 10,000 Nvidia chips, marking entry into AI Factory business segment.

Product Launch · Asia

Syfe

Syfe launched Cash+ Enhanced, a Singapore dollar cash management product offering up to 3.0% projected net yield, with no lock-in period or minimum deposit, available from 18 August 2026.

Product Launch · Asia

Fractal Analytics

Fractal Analytics launched India's first healthcare AI model as part of the India AI Mission, a pilot partnership with Brihanmumbai Municipal Corporation (BMC) delivering a Health AI Chatbot on WhatsApp.

Product Launch · Asia

Panasonic

Panasonic launched the LUMIX L10 fixed-lens camera in India, priced at ₹1,79,990, featuring a Leica zoom lens, 20.4MP sensor, and AI autofocus capabilities.

Product Launch · Asia

Biogen

Biogen's monoclonal antibody felzartamab received first global approval in China for second-line multiple myeloma treatment, in combination with lenalidomide and dexamethasone.

Where this lands in our work

Weekly briefing

Track companies like LexisNexis Risk Solutions — with our analysis

Anyone can set an alert for one company. We send a weekly read on the whole peer set — who's moving, and what it means for leadership. Pick what to follow:

Intelligence powered by Autonodal ↗